Showing results (161-170 of 173) with videos related to
Sort By:
Pageof 18
Molecular and Clinical Oncology|October 23, 2018
Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility studyTakeshi Masuda, Masako Watanabe, Kazunori Fujitaka, et al.Research in Diagnostic and Interventional Imaging|July 30, 2024
Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysisDaisuke Kawahara, Takeshi Masuda, Riku Nishioka, et al.Lung Cancer (Amsterdam, Netherlands)|April 9, 2008
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelinKota Iwahori, Tadashi Osaki, Satoshi Serada, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 20, 2023
Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in JapanKeitaro Omori, Hiroki Kitagawa, Kakuhiro Yamaguchi, et al.Internal Medicine (Tokyo, Japan)|September 21, 2021
Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4Hiroki Tanahashi, Kakuhiro Yamaguchi, Tomoko Koura, et al.Journal of Asthma and Allergy|November 1, 2022
Association Between Patient Preference for Inhaler Medications and Asthma OutcomesYu Nakanishi, Hiroshi Iwamoto, Shintaro Miyamoto, et al.Scientific Reports|May 13, 2021
Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patientsKakuhiro Yamaguchi, Satoshi Nakao, Hiroshi Iwamoto, et al.Journal of Clinical Medicine|October 14, 2022
Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot TrialHironobu Hamada, Kiyokazu Sekikawa, Ken Okusaki, et al.BMC Pulmonary Medicine|June 30, 2022
Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancerNaokazu Watari, Kakuhiro Yamaguchi, Hiroaki Terada, et al.Translational Lung Cancer Research|April 15, 2026
Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort studyAkio Nomura, Takeshi Masuda, Kiyofumi Shimoji, et al.Pageof 18